3D Bioprinting: Decoding the Future Evolution

Roots Analysis has announced the addition of 3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035’ report to its list of offerings. The report provides a comprehensive analysis of the current landscape and future outlook of the growing market of 3D bioprinting within the healthcare domain.

Kavya Verma, the principal analyst, stated, “The current applications of 3D bioprinted products in the pharmaceutical industry cater to the various requirements for clinical testing of therapeutic drugs. Owing to the evident interspecies differences, drug candidates that are shown to be efficacious in animal models often fail in humans. To overcome such challenges, 3D bioprinting can be used to develop more accurate, human specific disease models. Clearly, the potential long-term application of 3D bioprinting is the production of synthetic and viable organs that can be transplanted in humans. This is anticipated to bridge the gap between the demand and supply of organs for transplantation purposes.”

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Amongst other things, the report features:

• A detailed overview of the current market landscape of 3D bioprinters and 3D bioprinted products, highlighting the contributions of industry and non-industry players, with information on the various technological aspects and key specifications of such technologies / products.
• Profiles of developers of bioprinting devices / technologies and bioprinted products. Each profile includes an overview of the company, information on their financials (wherever available), details on their respective product portfolios, 3D bioprinting specific collaborations, and an informed future outlook.
• A comprehensive product competitiveness analysis of existing 3D bioprinters, based on supplier power and product specific features, such as the type of technology and the range of applications.
• An analysis of the partnerships that have been established in the recent past, covering research agreements, distribution agreements, product development agreements and other relevant deals, along with information on the collaborators / partners.
• An analysis of the investments made at various stages of development, such as seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings received by companies that are focused in this area.
• An analysis depicting the prevalent and emerging trends in 3D bioprinting as observed on the social media platform, Twitter. The report also includes a detailed case study on the upcoming trends, such as use of stem cells as bioinks, emergence of the concept of 4D bioprinting and commercialization of low-cost bioprinters, based on inputs from primary and secondary research.
• An analysis of intellectual property portfolio related to 3D bioprinting. The study presents a high-level view on the granted patents and submitted patent applications related to these technologies, highlighting the prevalent trends in this domain. In addition, the analysis highlights the most active geographies and the key players driving innovation in this field.

Verma further added, “The current market landscape of 3D bioprinting is characterized by the presence of nearly equal number of industry and non-industry players, featuring a number of start-ups and university spin-offs. The field has seen the emergence of several new players in the past few years; in fact, several well-known players of the 3D printing industry have broadened their focus to launch new initiatives specific to 3D bioprinting.Although several 3D bioprinting technologies are already available, active efforts are being made to add to the intellectual property portfolio. The field has witnessed growing partnering activity and has also managed to capture the interest of both public and private sector investors.”

The report highlights the contributions of several players in the field; some of the examples are listed below:

• 3Dynamic Systems
• Aspect Biosystems
• Allevi (formerly BioBots)
• BioDan Group
• CELLINK
• EnvisionTEC
• GeSiM
• MEDPRIN BIOTECH
• microdrop Technologies
• MicroFab Technologies
• Nano3D Biosciences
• Organovo
• Qingdao Unique Products Develop
• regenHU
• SunP Biotech International

The opinions and insights discussed in this report were influenced by valuable inputs from senior stakeholders in the industry. The report features detailed transcripts of interviews held with Douglas Chrisey (Professor, Tulane University), Lisa Oliver (Doctor, University of Nantes) and Fanny Geraldo (Engineer, University of Nantes), Glauco R Souza (President and Chief Scientific Officer, n3D Biosciences), Igor Zlatkin (Application Scientist, Digilab), Kenneth Church (President and Chief Executive Officer, nScrypt) and Xudong Chen (Executive Vice President Business Development & Sales, nScrypt), Laura Bosworth (Chief Executive Officer and Co-founder, TeVido BioDevices), Lauralyn McDaniel (Industry Manager, SME), Marc Thurner (Chief Executive Officer, regenHU), Roger Narayan (Professor, North Carolina State University) and Simon Fried (Chief Business Officer, Nano Dimension).

For additional details, please visit 

https://www.rootsanalysis.com/reports/view_document/3d-bioprinting-technologies-products-and-key-application-areas-2nd-edition-2018-2035/182.html or email sales@rootsanalysis.com

About Roots Analysis

Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at  info@rootsanalysis.com